Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.